Otologic Pharmaceutics, Inc.
- UEI
- MCYMZ54X6TK3
- CAGE
- 5QN87
- Primary NAICS
- 541711 Research and Development in Biotechnology
- SAM.gov registration
- Deleted
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Website
- otologicpharmaceutics.com
- Founded
- 2011
- Employees
- 1-10
- Industry
-
- Financials
- Diversified Financials
- Capital Markets
- Diversified Capital Markets
- SIC code
- 67 Holding & Other Investment Offices
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Nihl drug study | Bureau of Medicine and Surgery (Navy) | $688,600 |
Quick answers
Is Otologic Pharmaceutics, Inc. registered in SAM.gov?
Otologic Pharmaceutics, Inc.'s SAM.gov registration was deleted on February 6, 2016.
What is Otologic Pharmaceutics, Inc.'s most recent federal award?
Otologic Pharmaceutics, Inc.'s most recent federal contract award is Nihl drug study (N6264512C4037), from Bureau of Medicine and Surgery (Navy), on August 15, 2012.
On GovTribe
See Otologic Pharmaceutics, Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors